These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10195628)

  • 1. Prevention of infection of influenza virus in DQ6 mice, a human model, by a peptide vaccine prepared according to the cassette theory.
    Matsuki N; Ogasawara K; Takami K; Namba K; Takahashi A; Fukui Y; Sasazuki T; Iwabuchi K; Good RA; Onoé K
    Vaccine; 1999 Mar; 17(9-10):1161-8. PubMed ID: 10195628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An investigation of the effect of H3-H3 peptide vaccine for preventing influenza virus infection in DQ6 mice].
    Matsuki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):171-9. PubMed ID: 9612710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice by peptide vaccines].
    Takahashi A
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):147-56. PubMed ID: 9612708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.
    Naruse H; Ogasawara K; Kaneda R; Hatakeyama S; Itoh T; Kida H; Miyazaki T; Good RA; Onoé K
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9588-92. PubMed ID: 7937811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of a peptide deduced from the influenza virus haemagglutinin that induces human class II-restricted T cell responses in DQ6 transgenic mice].
    Takami K
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):329-42. PubMed ID: 7774884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory.
    Naruse H; Ogasawara K; Takami K; Kajino K; Gotohda T; Itoh Y; Miyazaki T; Good RA; Onoè K
    Vaccine; 1994 Jul; 12(9):776-82. PubMed ID: 7526571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of synthetic peptide vaccine against influenza--T cell epitope the hemagglutinin of A/Aichi/2/68(H3N2) influenza virus induced immune response in mice].
    Naruse H
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):811-20. PubMed ID: 7525436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice.
    Takahashi A; Ogasawara K; Matsuki N; Fujinaga K; Nakaya T; Ikuta K; Auwanit W; Honda M; Fukui Y; Sasazuki T; Iwabuchi K; Onoé K
    Vaccine; 1998 Oct; 16(16):1537-43. PubMed ID: 9711801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for making synthetic peptide vaccines.
    Ogasawara K; Naruse H; Itoh Y; Gotohda T; Arikawa J; Kida H; Good RA; Onoé K
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8995-9. PubMed ID: 1409595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an HLA-DQ6-derived peptide recognized by mouse MHC class I H-2Db-restricted CD8+ T cells in HLA-DQ6 transgenic mice.
    Takeshita T; Fukui Y; Yamamoto K; Yamane K; Inamitsu T; Kamikawaji N; Sasazuki T
    Jpn J Hum Genet; 1997 Mar; 42(1):225-32. PubMed ID: 9184003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the agretopic residues of a peptide co-restricted to different class II isotypes, I-Au and I-Eu, and its application for preparation of a synthetic peptide vaccine against influenza virus A/Aichi/2/68.
    Takami K; Ogasawara K; Itoh Y; Kajino K; Naruse H; Onoé K
    Microbiol Immunol; 1994; 38(10):779-87. PubMed ID: 7532781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
    Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
    J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice.
    Raju R; Munn SR; David CS
    Hum Immunol; 1997 Nov; 58(1):21-9. PubMed ID: 9438206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ6 and HLA-DQ8 transgenic mice respond to ragweed allergens and recognize a distinct set of epitopes on short and giant ragweed group 5 antigens.
    Chapoval SP; Neeno T; Krco CJ; Marietta EV; Harders J; David CS
    J Immunol; 1998 Aug; 161(4):2032-7. PubMed ID: 9712076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.